Who owns Atopica?
Atopica is owned by Elanco (the United States, NYSE: ELAN).[1]
Evidence: Elanco Animal Health Incorporated Annual Report on Form 10-K filed 2026-02-24, SEC EDGAR, 24 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Elanco Animal Health Incorporated verified
- Owner HQ
- 🇺🇸 United States, Indianapolis
- Origin
- 🇺🇸 United States
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- NYSE: ELAN
- Trademark registrant
- ELANCO TIERGESUNDHEIT AG (USPTO)
- Last verified
- · 2 sources
About Atopica
Atopica is a dermatology medicine for dogs that Elanco's 10-K lists among its pet health products as a treatment that controls atopic dermatitis. It sits in the same Elanco portfolio as Zenrelia and the newly approved anti-IL31 antibody Befrena, which target canine itch and allergic skin disease. Elanco lists it in the animal-health portfolio described in its annual report on Form 10-K for the year ended 31 December 2025.
How often Elanco names Atopica in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central.
Trademark record for Atopica
The USPTO record for the Atopica mark lists ELANCO TIERGESUNDHEIT AG as the owner of record (serial number 78007844). That name matches the owner named above.[2]
Ownership timeline of Atopica
Where Atopica sits in Elanco
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Elanco ownership tree →
See the full Elanco brand portfolio (15) →
Other brands owned by Elanco
Elanco controls 15 brands on Brandtree, 15 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
The 45 brands in veterinary services on Brandtree belong to 7 owners. The largest is Zoetis, with 17; Elanco has 10.
About the owner: Elanco
Elanco is a publicly listed company headquartered in Indianapolis, United States, founded in 1954. Brandtree records 15 brands under its control, and it is listed as NYSE: ELAN.
Elanco Animal Health is an Indianapolis animal health company with pet health and farm animal businesses. Its 10-K says it has a heritage dating to 1954 as a business unit of Eli Lilly and Company, was incorporated independently in September 2018 and separated in March 2019, and in August 2020 acquired Bayer Animal Health, which it calls the largest acquisition in industry history. It sells flea and tick, dermatology and pain products for pets and feed additives, vaccines and antibiotics for livestock.
🇺🇸 Atopica and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Atopica is not one of them.
- 4health — Tractor Supply 🇺🇸
- American Journey — Chewy 🇺🇸
- Apoquel — Zoetis 🇺🇸
- Aqueon — Central Garden & Pet 🇺🇸
- Aureomycin — Phibro 🇺🇸
- BARK — BARK 🇺🇸
Frequently asked questions
Who is the parent company of Atopica?
The parent company of Atopica is Elanco, a publicly listed company headquartered in the United States.
Is Atopica American?
Yes. Atopica originated in the United States and its owner, Elanco, is also headquartered in the United States.
Is Atopica still owned by Elanco?
Yes. As of 2 October 2026, Atopica is still owned by Elanco. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Elanco Animal Health Incorporated Annual Report on Form 10-K filed 2026-02-24 — SEC EDGAR, SEC Form 10-K, published 24 February 2026; retrieved 2 October 2026.
- [2] USPTO: ATOPICA, serial 78007844 — United States Patent and Trademark Office, Trademark registry; retrieved 2 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.